Gut Liver.  2014 Jul;8(4):452-458.

beta-Catenin Activated Hepatocellular Adenoma: A Report of Three Cases in Korea

Affiliations
  • 1Department of Pathology, Yonsei University College of Medicine, Seoul, Korea. young0608@yuhs.ac
  • 2Department of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • 3Department of Radiology, Research Institute of Radiological Science, Yonsei University Severance Hospital, Seoul, Korea.
  • 4Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
  • 5Department of Pathology, The Mount Sinai Medical Center, New York, NY, USA.

Abstract

Hepatocellular adenoma (HCA) is an uncommon benign hepatic tumor, and the use of oral contraceptives is known to contribute to the development of HCA. Recently, a genotype and phenotype classification system for HCA was suggested, and malignant transformation to hepatocellular carcinoma (HCC) was shown to be strongly associated with activating mutations in beta-catenin. Here, we report three cases of HCA in Korean patients: 7-cm, inflammatory and beta-catenin-activated HCA with HCC transformation in a 46-year-old man; 13-cm, beta-catenin-activated HCA with cytological atypia in a 23-year-old woman; and 10-cm, pigmented, inflammatory and beta-catenin-activated HCA in a 36-year-old man. All cases exhibited the nuclear expression of beta-catenin and diffuse cytoplasmic expression of glutamine synthetase upon immunohistochemical staining. All tumors were completely resected, and the patients were followed for 3 to 6 years with no evidence of local recurrence or metastasis.

Keyword

Adenoma, liver cell; Beta catenin; Carcinoma, hepatocellular; Glutamine synthetase

MeSH Terms

Adult
Carcinoma, Hepatocellular/*metabolism
Female
Humans
Liver Neoplasms/*metabolism
Male
Middle Aged
Republic of Korea
Young Adult
beta Catenin/*metabolism
beta Catenin
Full Text Links
  • GNL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr